Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Leadership Team - Inotrem
Board – ENYO Pharma
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin
5 September 2011
COMPANY | Inotrem
Zimmermann replaces ex-Roche pRED chief as Inotrem CEO | Fierce Biotech
Jean-Jacques Garaud | Nature Reviews Drug Discovery
Jacques Chirac - Wikipedia
KEYSTONE SYMPOSIA Connecting the Scientific Community Keystone Symposia is a 501(c)3 nonprofit directed and supported by the scientific community. Conferences. - ppt download
Andera Partners s'entretient avec Jean-Jacques Garaud, CEO d'INOTREM, au portefeuille de notre équipe Andera Life Sciences on Vimeo
Inotrem closes $43M series B round for phase IIb trial of nangibotide in septic shock | 2019-09-12 | BioWorld
138 Marie France Garaud Photos and Premium High Res Pictures - Getty Images
Registering Clinical Trials
Leadership Team - Inotrem
112 Marie France Garaud Photos and Premium High Res Pictures - Getty Images
Jean-Jacques Garaud - Co-Founder, Executive Vice-President, Scientific and Medical Affairs @ Inotrem - Crunchbase Person Profile
COMPANY | Inotrem
Roche unterzeichnet Vereinbarung zur Übernahme von Anadys Pharmaceuticals
Leadership Team - Inotrem
Inotrem sparks hope with new phase 2b data
Hybridays 2021: Jean-Jacques GARAUD, CEO at Inotrem - YouTube
Founders – ENYO Pharma
Inotrem announces €39 Million Series B Financing to Develop First- In-Class Immunology Therapeutics
